CD BioGlyco Launches Targeted Antibody Deglycosylation Services to Advance Biopharmaceutical Research
CD BioGlyco, a leading provider of glycosylation-related services, is proud to announce the launch of its specialized antibody deglycosylation services, including Hydrolysis of All Fc-Glycans and Hydrolysis of Complex-Type N-Glycans. These services are designed to help pharmaceutical and biotechnology companies better understand and optimize the role of glycosylation in therapeutic antibodies, ultimately leading to more effective…
bioglycoRhamnolipids: Biosynthetic Pathways and Industrial Potential
Introduction to Rhamnolipids Rhamnolipids are a class of biosurfactants that have garnered significant interest in various scientific and industrial sectors. These amphiphilic molecules, composed of rhamnose sugar moieties and β-hydroxy fatty acids, exhibit exceptional surface-active properties. Their biodegradability, low toxicity, and environmentally friendly profile make them ideal candidates for applications in pharmaceuticals, agriculture, cosmetics,…